The Protocol Followed in the French COVID-19 Drug Combo Study

Didier Raoult M.D, PhD is the Professor of Medicine at Universite d'Aix-Marseille and is on the frontlines of working to discover an effective treatment for COVID-19 patients. On Mar. 23, 2020's episode of The Dr. Oz Show, Dr. Oz interviewed Dr. Raoult via Zoom to find out more, including, how quickly Americans may or may not adopt the same technique. 

This is what was done in Dr. Raoult's French study and what we're going to use in our own study in America. Dr. Raoult also emphasized the importance of looking for heart issues before beginning.

RELATED: Subscribe to the Dr. Oz newsletter for wellness tips, recipes, and exclusive sneak peeks from The Dr. Oz Show.

The Process:

Patients with COVID-19 infection are treated with hydroxychloroquine and azithromycin.

Plaquenil 200mg x3/day (10 days), and azithromycine 250mg for five days, twice the first day, then once for the next four days.

In order to avoid cardiac problems, an ECG is done before starting treatment, and in order to assess lung damage, a low-dose CT scan is performed.

The evaluation of the virological effect consists of a PCR before inclusion, with the quantification of the viral load on a nasopharyngeal sample, and a PCR on D5 to verify that the virus is undetectable or at levels too low to present a contagious risk.

Presentation of the study:

Paper in the International Journal of Antimicrobial Agents:

Disclaimer: This medication regimen is still being studied. Do not take these medications without the guidance of a doctor.